Clinical trial
DAGMAR: Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression
NCT04880369 is registered in ClinicalTrials.gov with Danish Cancer Society as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DAGMAR: Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression
- Lead sponsor
- Danish Cancer Society
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- March 31, 2021
- Completion date
- December 31, 2022
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, breast cancer female, breast neoplasms